Apogee Therapeutics Inc. (NASDAQ: APGE) closed the day trading at $55.05 down -5.15% from the previous closing price of $58.04. On the day, 583616 shares were traded.
Ratios:
For a better understanding of APGE, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 19.38 and its Current Ratio is at 19.38. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, BTIG Research on December 20, 2023, initiated with a Buy rating and assigned the stock a target price of $43.
On August 08, 2023, Wedbush started tracking the stock assigning a Outperform rating and target price of $40.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jul 13 ’23 when Fairmount Funds Management LLC bought 2,941,176 shares for $17.00 per share. The transaction valued at 49,999,992 led to the insider holds 1,992,734 shares of the business.
Shah Nimish P bought 1,750,000 shares of APGE for $29,750,000 on Jul 13 ’23. The Director now owns 1,750,000 shares after completing the transaction at $17.00 per share.
Stock Price History:
Over the past 52 weeks, APGE has reached a high of $72.29, while it has fallen to a 52-week low of $14.19.
Shares Statistics:
A total of 37.17M shares are outstanding, with a floating share count of 35.08M. Insiders hold about 5.66% of the company’s shares, while institutions hold 81.77% stake in the company.
Earnings Estimates
Current recommendations for the stock of the company come from AVGE analysts. The consensus estimate for the next quarter is $55.05, with high estimates of $38.56 and low estimates of $15.82.
Analysts are recommending an EPS of between $Industrials and $Real Estate for the fiscal current year, implying an average EPS of $Healthcare.
